ARTICLE | Company News
Merck submits Arcoxia NDA
October 11, 2001 7:00 AM UTC
MRK submitted an NDA to the FDA for Arcoxia etoricoxib, a specific cyclooxygenase-2 (COX-2) inhibitor, to treat arthritis and pain. The product is MRK's second COX-2 inhibitor, behind Vioxx rofecoxib ...